An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these accounts directly for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Express Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting substances of unknown origin.
Several experts stated the demand for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.
Service Response and Material Elimination
According to TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Investigations also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, glowing testimonials and detailed instructions for mixing or injecting at residence.
After minutes of entering one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience.
Product Information and Costs
Inside these groups, posts display black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is sound, these online versions may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.
Her team has already seen patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially significant health risks”.
